Pre-Clinical (Discovery and Development)

Find out how to fill up your pipeline and increase innovation. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in early discovery and preclinical research to exchange ideas on best practice and share case studies on innovation within the area.
 

The Top 10 Pharmaceutical & Biotechnology R&D Investors

Contributor: Pharma IQ
Posted: 4/30/2014

The Top 10 Pharmaceutical & Biotechnology R&D Investors - Pharma IQ

Research based pharmaceutical companies are always striving to make advancements in science and technology, but this innovation comes at a price R&D investment. Research and development of new therapies involves a complex expensive, time-intensive and risk process. We take a closer look below at the Top 10 Pharmaceutical & Biotechnology R&D Investors in the world. Full Article »


Events related to this topic:

Utilising Big Data for Bioscience Product Development

Contributor: Diana Davis
Posted: 7/3/2014


Utilising Big Data for Bioscience Product Development - Diana Davis

Big data is turning up everywhere. In this Process Perspectives podcast, Kaare Buch Petersen, Information Architect in Global IT at Christen Hansen, a Denmark-based supplier of bioscience products to food and health industries, talks about how his company has been using big data in the development of their new products. Full Podcast »


Events related to this topic:

Don’t Push That Single (Placebo) Target!

Contributor: Jonas Boström
Posted: 9/29/2014


Don’t Push That Single (Placebo) Target! - Jonas Boström

Is pharma looking at target selection in the wrong way? Is the prevailing one drug, one target ideal just an illusion? In this column, Jonas Boström compares this drug discovery methodology to the placebo buttons in pedestrian crossings, as they give merely the illusion of control. Full Column »


Events related to this topic:

The 2015 Biobanking Industry Outlook

Biobanks sit in the heart of R&D, serving as a biological sample library for researchers and clinicians. Now, biobanks are progressing forward towards automated biobanking to improve sample management and utilisation, as well as becoming sample information warehouses through the implementation of advanced data management systems. Ahead of the 7th annual Global Biobanking Summit, Pharma IQ surveyed biobank and sample management professionals across both public and private sectors and identified growth plans and trends in investment. This infographic the reveals key findings from the 2015 Biobanking Industry Survey. Full Whitepaper »


Events related to this topic:



Advertise With Us

Join the Pharmas IQ Community